Data presented at AHS meeting support further development of G-3139 in combination regimens Dec. 7, 2000
Tezacitabine, an antimetabolite nucleoside analogue, assessed in hematological malignancies Dec. 7, 2000
Synthetic camptothecin derivative shows potential in AML and other hematological malignancies Dec. 7, 2000
Chemically modified homoharringtonine analogue retains activity against resistant leukemia cells Dec. 5, 2000
RSS